US PATENT SUBCLASS 530 / 388.7
.~.~.~.~.~.~ Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)


Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use



530 /   HD   CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF

350  DF  PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES {14}
380  DF  .~ Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. {3}
386  DF  .~.~ Globulins {4}
387.1  DF  .~.~.~ Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed {9}
388.1  DF  .~.~.~.~ Monoclonal {3}
388.2  DF  .~.~.~.~.~ Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.) {12}
388.7.~.~.~.~.~.~ Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.) {1}
388.73  DF  .~.~.~.~.~.~.~> Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage acute lymphoblastic leukemia cell, B-lymphocytic cell-surface antigen, etc.) {1}


DEFINITION

Classification: 530/388.7

Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.):

(under subclass 388.2) Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose

antigen-binding site(s) will combine with an integral or isolated part of a hematopoietic cell, or with a substance shed or secreted by a hematopoietic cell.

(1) Note. Hematopoietic cells are considered to be bone marrow stem cells and cells derived from bone marrow stem cells, including cells at any stage of differentiation from progenitor cells to mature erythrocytes, granulocytes, lymphocytes, etc., both normal and neoplastic.